Cargando…

The development of COVID-19 treatment

The emergence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) caused a pandemic named coronavirus disease 2019 (COVID-19) that has become the greatest worldwide public health threat of this century. Recent studies have unraveled numerous mysteries of SARS-CoV-2 pathogenesis and thus...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yuan, Yongliang, Jiao, Baihai, Qu, Lili, Yang, Duomeng, Liu, Ruijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9909293/ https://www.ncbi.nlm.nih.gov/pubmed/36776881 http://dx.doi.org/10.3389/fimmu.2023.1125246

Ejemplares similares

The Interplay between Immune and Metabolic Pathways in Kidney Disease
por: Qu, Lili, et al.
Publicado: (2023)

Effect of extracorporeal hemoadsorption in critically ill patients with COVID-19: A narrative review
por: Chang, Kaixi, et al.
Publicado: (2023)

Pharmacological Inhibition of STAT6 Ameliorates Myeloid Fibroblast Activation and Alternative Macrophage Polarization in Renal Fibrosis
por: Jiao, Baihai, et al.
Publicado: (2021)

Development of a Novel Immune-Related Gene Prognostic Index for Breast Cancer
por: Yao, Yan, et al.
Publicado: (2022)

Systemic Immune-Inflammation Index Is Associated With Increased Urinary Albumin Excretion: A Population-Based Study
por: Qin, Zheng, et al.
Publicado: (2022)

COVID-19 in Association With Development, Course, and Treatment of Systemic Autoimmune Rheumatic Diseases
por: Lakota, Katja, et al.
Publicado: (2021)

Evaluation of anifrolumab safety in systemic lupus erythematosus: A meta-analysis and systematic review
por: Liu, Zhihui, et al.
Publicado: (2022)

Role of NLRP3 inflammasome in diabetes and COVID-19 role of NLRP3 inflammasome in the pathogenesis and treatment of COVID-19 and diabetes NLRP3 inflammasome in diabetes and COVID-19 intervention
por: Zhang, Jiayu, et al.
Publicado: (2023)

Efficacy of Thymosin Alpha 1 in the Treatment of COVID-19: A Multicenter Cohort Study
por: Liu, Jiao, et al.
Publicado: (2021)

Diagnosis and treatment for the early stage of cytomegalovirus infection during hematopoietic stem cell transplantation
por: Cui, Jiaqi, et al.
Publicado: (2022)

Landscape of Peripheral Blood Mononuclear Cells and Soluble Factors in Severe COVID-19 Patients With Pulmonary Fibrosis Development
por: Wang, Zhuolin, et al.
Publicado: (2022)

COVID-19: Coronavirus Vaccine Development Updates
por: Zhao, Jing, et al.
Publicado: (2020)

Vaccine development for mosquito-borne viral diseases
por: Huang, Zhiwei, et al.
Publicado: (2023)

Overview of Breastfeeding Under COVID-19 Pandemic
por: Pang, Zehan, et al.
Publicado: (2022)

The relationship between gut microbiota and COVID-19 progression: new insights into immunopathogenesis and treatment
por: Wang, Man, et al.
Publicado: (2023)

Cytokine Storm in COVID-19: The Current Evidence and Treatment Strategies
por: Tang, Yujun, et al.
Publicado: (2020)

Circulating Histones in Sepsis: Potential Outcome Predictors and Therapeutic Targets
por: Li, Yupei, et al.
Publicado: (2021)

Presence of Anti-MDA5 Antibody and Its Value for the Clinical Assessment in Patients With COVID-19: A Retrospective Cohort Study
por: Wang, Geng, et al.
Publicado: (2021)

Vaccine development against tuberculosis before and after Covid-19
por: Kaufmann, Stefan H. E.
Publicado: (2023)

Immunesenescence: A Predisposing Risk Factor for the Development of COVID-19?
por: Hazeldine, Jon, et al.
Publicado: (2020)

A comprehensive analysis of the efficacy and effectiveness of COVID-19 vaccines
por: He, Xiaofeng, et al.
Publicado: (2022)

Molnupiravir and Its Antiviral Activity Against COVID-19
por: Tian, Lili, et al.
Publicado: (2022)

SOCS, Intrinsic Virulence Factors, and Treatment of COVID-19
por: Johnson, Howard M., et al.
Publicado: (2020)

Interferon-α2b Treatment for COVID-19
por: Zhou, Qiong, et al.
Publicado: (2020)

Lack of Effectiveness of Repurposed Drugs for COVID-19 Treatment
por: Martinez, Miguel Angel
Publicado: (2021)

Editorial: Neutralizing Antibodies in the Prevention and Treatment of COVID-19
por: Razonable, Raymund R., et al.
Publicado: (2022)

Lipidomic insights into the immune response and pearl formation in transplanted pearl oyster Pinctada fucata martensii
por: Wu, Hailing, et al.
Publicado: (2022)

Exploration of the common genetic landscape of COVID-19 and male infertility
por: Chen, Yinwei, et al.
Publicado: (2023)

A Review of the Progress and Challenges of Developing a Vaccine for COVID-19
por: Sharma, Omna, et al.
Publicado: (2020)

Mesenchymal stem/stromal cells- a principal element for tumour microenvironment heterogeneity
por: Sun, Li, et al.
Publicado: (2023)

The Role of Type I Interferons in the Pathogenesis and Treatment of COVID-19
por: Schreiber, Gideon
Publicado: (2020)

Corrigendum: Interferon-α2b Treatment for COVID-19
por: Zhou, Qiong, et al.
Publicado: (2020)

Why Haven’t We Found an Effective Treatment for COVID-19?
por: Spicer, Alexander James, et al.
Publicado: (2021)

Tumor microenvironment-mediated immune tolerance in development and treatment of gastric cancer
por: Liu, Yuanda, et al.
Publicado: (2022)

The Transient IFN Response and the Delay of Adaptive Immunity Feature the Severity of COVID-19
por: Xu, Gang, et al.
Publicado: (2022)

Immune Response to COVID-19 During Pregnancy
por: Chen, Ge, et al.
Publicado: (2021)

Co-Expression of Mitochondrial Genes and ACE2 in Cornea Involved in COVID-19
por: Yuan, Jian, et al.
Publicado: (2020)

Polymorphisms and gene expression of Notch4 in pulmonary tuberculosis
por: Fang, Weijun, et al.
Publicado: (2023)

Monoclonal antibodies constructed from COVID-19 convalescent memory B cells exhibit potent binding activity to MERS-CoV spike S2 subunit and other human coronaviruses
por: Peng, Yuan, et al.
Publicado: (2022)

Active regression model for clinical grading of COVID-19
por: Sh, Yuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v4aca291i4ju35pnvoj518kfn7